Ravulizumab-cwvz 300 mg in 3 mL Injection
RxNorm 2461139 NDC Crossover

NDC Directory Crossover & Product Mapping

The following National Drug Codes (NDCs) are directly associated with the clinical concept for Ravulizumab-cwvz 300 mg in 3 mL Injection (RxCUI 2461139). This crossover tool provides a verified mapping between standardized RxNorm clinical drug definitions and the specific manufactured products listed in the FDA NDC directory.

Healthcare professionals, pharmacists, and data analysts use this list to identify various brand names, labelers, and commercial packaging variations linked to this semantic clinical drug concept. Each entry below represents a commercial product that fulfills the requirements of this specific clinical identifier.

Manufacturer Quick Index

→ Alexion Pharmaceuticals Inc. 3

Alexion Pharmaceuticals Inc.

NDC Product
Human Prescription Drug

Ultomiris
NDC 25682-022

Generic Name
Ravulizumab
Dosage Form
Solution, Concentrate
Route
Intravenous
Marketing
BLA
Active Listing
NDC Product
Human Prescription Drug

Ultomiris
NDC 25682-025

Generic Name
Ravulizumab
Dosage Form
Solution, Concentrate
Route
Intravenous
Marketing
BLA
Active Listing
NDC Product
Human Prescription Drug

Ultomiris
NDC 25682-028

Generic Name
Ravulizumab
Dosage Form
Solution, Concentrate
Route
Intravenous
Marketing
BLA
Active Listing